Literature DB >> 14729959

The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Koji Nakade1, Hong Zheng, Gitali Ganguli, Gilles Buchwalter, Christian Gross, Bohdan Wasylyk.   

Abstract

The tumor suppressor function of p53 is linked to its ability to repress gene expression, but the mechanisms of specific gene repression are poorly understood. We report that wild-type p53 inhibits an effector of the Ras oncogene/mitogen-activated protein (MAP) kinase pathway, the transcription factor Net. Tumor-associated mutant p53s are less efficient inhibitors. p53 inhibits by preventing phosphorylation of Net by MAP kinases. Loss of p53 in vivo leads to increased Net phosphorylation in response to wound healing and UV irradiation of skin. Our results show that p53 can repress specific gene expression by inhibiting Net, a factor implicated in cell cycle entry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729959      PMCID: PMC321436          DOI: 10.1128/MCB.24.3.1132-1142.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Identification and classification of p53-regulated genes.

Authors:  J Yu; L Zhang; P M Hwang; C Rago; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.

Authors:  C Ducret; S M Maira; Y Lutz; B Wasylyk
Journal:  Oncogene       Date:  2000-10-19       Impact factor: 9.867

4.  The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.

Authors:  S D'Souza; H Xin; S Walter; D Choubey
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

5.  Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.

Authors:  N Ragimov; A Krauskopf; N Navot; V Rotter; M Oren; Y Aloni
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

6.  The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain.

Authors:  R Marais; J Wynne; R Treisman
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

7.  Repression of RNA polymerase I transcription by the tumor suppressor p53.

Authors:  W Zhai; L Comai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.

Authors:  G Ganguli; J Abecassis; B Wasylyk
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

9.  Regulation of the human hsp70 promoter by p53.

Authors:  S N Agoff; J Hou; D I Linzer; B Wu
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  Distinct TFIID complexes mediate the effect of different transcriptional activators.

Authors:  C Brou; S Chaudhary; I Davidson; Y Lutz; J Wu; J M Egly; L Tora; P Chambon
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  7 in total

1.  Elk3 is essential for the progression from progenitor to definitive neural crest cell.

Authors:  Crystal D Rogers; Jacquelyn L Phillips; Marianne E Bronner
Journal:  Dev Biol       Date:  2012-12-22       Impact factor: 3.582

Review 2.  The Paradox of p53: What, How, and Why?

Authors:  Yael Aylon; Moshe Oren
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

3.  p53-Dependent regulation of Cdc6 protein stability controls cellular proliferation.

Authors:  Anja Duursma; Reuven Agami
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 4.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

5.  p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells.

Authors:  Shui Ping Tu; Alfred L Chi; Walden Ai; Shigeo Takaishi; Zina Dubeykovskaya; Michael Quante; James G Fox; Timothy C Wang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-18       Impact factor: 4.052

6.  Net expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivo.

Authors:  Baiwen Li; Xinjian Wan; Qi Zhu; Lei Li; Yue Zeng; Duanmin Hu; Yueqin Qian; Lungen Lu; Xingpeng Wang; Xiangjun Meng
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Down-regulation of LATS kinases alters p53 to promote cell migration.

Authors:  Noa Furth; Noa Bossel Ben-Moshe; Yair Pozniak; Ziv Porat; Tamar Geiger; Eytan Domany; Yael Aylon; Moshe Oren
Journal:  Genes Dev       Date:  2015-11-15       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.